BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 18644010)

  • 1. Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Prasad R; McCloskey C; Gilmour D; Morran CG
    Aliment Pharmacol Ther; 2008 Oct; 28(7):878-85. PubMed ID: 18644010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
    Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
    Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches.
    Di Carlo I; Toro A; Sparatore F; Primo S; Barbagallo F; Di Blasi M
    Minerva Chir; 2006 Aug; 61(4):325-32. PubMed ID: 17122765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
    Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
    Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
    Johnson TW; Anderson KE; Lazovich D; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of serious complicated gastroduodenal ulcers in Japan.
    Ishikawa S; Inaba T; Mizuno M; Miyake Y; Okada H; Ishikawa H; Hori K; Wato M; Kawai K; Yamamoto K
    Hepatogastroenterology; 2012; 59(113):147-54. PubMed ID: 22251530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting mortality and morbidity in patients with peptic ulcer perforation.
    Kocer B; Surmeli S; Solak C; Unal B; Bozkurt B; Yildirim O; Dolapci M; Cengiz O
    J Gastroenterol Hepatol; 2007 Apr; 22(4):565-70. PubMed ID: 17376052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
    J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
    Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
    Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs.
    Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
    Aliment Pharmacol Ther; 2005 Aug; 22(4):285-9. PubMed ID: 16097994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?
    Langman MJ
    Pharmacoepidemiol Drug Saf; 2001; 10(1):13-9. PubMed ID: 11417061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of peptic ulcer in 4943 inpatients.
    Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I
    J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of NSAID associated gastrointestinal disease.
    Wolfe F
    Eur J Rheumatol Inflamm; 1991; 11(3):12-28. PubMed ID: 1365476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study.
    Hayes JH; Anderson KE; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2226-31. PubMed ID: 17119050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.